Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byRetroScreen Virology
Price£4M
Date3/2014
TermsCash and Stock

General Information

Offices

London, GBR
24 Cornhill
London, EC3V 3ND, GBR

People

Director
Founding Director
Founding Director
Non-Exec Director

Funding

TOTAL $805k
FUNDING TOTAL $805k
Venture Round, 3/2011
IP Group Plc
IP Venture Fund
$805k

Tags

Activiomics

Activiomics Ltd. has developed a groundbreaking and patented technology that will enable a transformation in the way in which biomarkers are identified, diagnostics are developed and drug candidates are identified and profiled.

Activiomics’ technology centres around novel mass spectrometry based approaches for the global quantitative analysis of phosphorylation sites. Phosphorylation is critical mediator all cellular processes and hence sites of phosphorylation represent an important class of novel biomarkers. Activiomics’ TIQUAS (Targeted In-depth QUAntification of cell Signalling) technology enables the quantification of thousands of phosphorylation events from a given tissue sample and the subsequent markers of response that are identified will enable the development of future diagnostics.

Recent Milestones

Videos

Screenshots

Activiomics screenshot
Above: Activiomics
Uploaded: 3/16/11

Sources

  1. Retroscreen Virology Group plc - Acquisition of Activiomics Ltd (ipgroupplc.com) [edit]
  2. Activiomics Inks $805,000 (equityhelpdesk.com) [edit]
Edit This Page
Last Edited 3/4/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy